| FFNCX | HBLAX | FFNCX / HBLAX | |
| Total Expense Ratio | 1.53 | 0.89 | 172% |
| Annual Report Gross Expense Ratio | 1.53 | 0.89 | 172% |
| Fund Existence | 18 years | 19 years | - |
| Gain YTD | 11.677 | 9.012 | 130% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 2000 | - |
| Min. Initial Investment IRA | 500 | 2000 | 25% |
| Net Assets | 2.48B | 11.7B | 21% |
| Annual Yield % from dividends | 1.54 | 3.29 | 47% |
| Returns for 1 year | 10.41 | 3.28 | 317% |
| Returns for 3 years | 26.67 | 18.19 | 147% |
| Returns for 5 years | 18.05 | 13.61 | 133% |
| Returns for 10 years | 45.77 | 45.05 | 102% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PPH | 99.43 | 0.10 | +0.10% |
| VanEck Pharmaceutical ETF | |||
| WEEK | 100.04 | N/A | N/A |
| Roundhill Weekly T-Bill ETF | |||
| YFYA | 9.86 | N/A | -0.02% |
| Yields for You Strategy A ETF | |||
| RLTY | 14.97 | -0.26 | -1.71% |
| Cohen & Steers Real Estate Opportunities and Income Fund | |||
| FCTR | 34.30 | -1.25 | -3.53% |
| First Trust Lunt US Factor Rotation ETF | |||